{
  "docId": "019de070-3b27-7318-9c92-a5817b78bd41",
  "docSlug": "ce86c4a3bf509aea21f24e2159890cb6",
  "documentTitle": "BioNTech | Results Presentation Deck | 28 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 28,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 15,
  "notes": "Includes process flow diagram, flow cytometry plots, and a scatter plot showing TCR frequency.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/12",
  "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41",
  "deckJsonHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41.json",
  "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.38,
        "w": 0.32,
        "x": 0.36,
        "y": 0.58
      },
      "kind": "chart",
      "text": "BNT122 induces CD8+ T cells in CPI-sensitive and CPI-insensitive tumor types",
      "attrs": null,
      "subkind": "scatter",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e1299e0-b172-4d75-a7f5-091cf70c5d3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.38,
        "w": 0.24,
        "x": 0.74,
        "y": 0.58
      },
      "kind": "chart",
      "text": "BNT122 induces CD8+ T cell Infiltrates in tumors",
      "attrs": null,
      "subkind": "scatter",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4990669d-ecbf-4882-a929-38f46441a600",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.42,
        "w": 0.32,
        "x": 0.02,
        "y": 0.515
      },
      "kind": "diagram",
      "text": "Evaluation of BNT122 safety & feasibility with/without Tecentriq in > 10 indications",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d10395de-8e55-49b4-976c-51cb06b0bece",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.32,
        "w": 0.72,
        "x": 0.24,
        "y": 0.18
      },
      "kind": "list",
      "text": "Data from ongoing Phase 1 trial in heavily pre-treated, PD-1 low patients across multiple tumor types; Demonstrated ability to elicit significant T cell responses; Treatment-related adverse events were primarily transient; Initial signals of clinical activity.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c17f5292-c942-4704-892f-8a36fb108fbf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.07,
        "y": 0.08
      },
      "kind": "title",
      "text": "iNeST: BNT122 recent AACR data update",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16c6decc-06e6-4baf-9e41-a4ab71d8c5aa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Data Story Arc",
      "slug": "data-story-arc",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "f4c92ec7-bd2a-40af-898b-37daabf0aa50",
      "evidence": "list/bullet: Data from ongoing Phase 1 trial",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 11,
      "beatId": "a7d0d755-e358-49e1-888b-58ab156af58d",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The presentation provides updates on the company's pipeline and progress in various trials",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 11,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "9d8a011b-49af-405a-9073-8a77c7487ff0",
      "evidence": "The presentation implies that not investing in innovative solutions could lead to missed opportunities",
      "position": 1,
      "objective": "What are the potential consequences of not investing in innovative solutions?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.5,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}